Toughening cross-linked thermosets
    14.
    发明授权
    Toughening cross-linked thermosets 有权
    增韧的交联热固性材料

    公开(公告)号:US09102807B2

    公开(公告)日:2015-08-11

    申请号:US14320698

    申请日:2014-07-01

    摘要: Grafted triglycerides comprising an acrylated triglyceride grafted with a fatty acid residue containing 4 to 28 carbon atoms. Also described are methods for making a grafted triglyceride and for curing a material selected from vinyl esters and unsaturated polyesters and mixtures thereof and optionally a reactive diluent. The method includes the steps of mixing a grafted triglyceride of the present invention with a material selected from vinyl esters, unsaturated polyesters and mixtures thereof to form a mixture, and curing the mixture to form a cured resin system. A cured resin system comprising a cured product obtained by the foregoing method and composites containing the cured product and a filler or reinforcing material are also disclosed. This method also includes use of the grafted triglycerides to make toughened resin and composite systems with reduced hazardous air pollutants without significantly reducing the glass transition temperature and significantly increasing the viscosity.

    摘要翻译: 接枝甘油三酸酯,其包含用含有4至28个碳原子的脂肪酸残基接枝的丙烯酸酯化的甘油三酯。 还描述了制备接枝甘油三酯和固化选自乙烯基酯和不饱和聚酯及其混合物和任选的反应性稀释剂的材料的方法。 该方法包括将本发明的接枝甘油三酯与选自乙烯基酯,不饱和聚酯及其混合物的材料混合以形成混合物,并固化该混合物以形成固化的树脂体系的步骤。 还公开了包含通过上述方法获得的固化产物和含有固化产物和填料或增强材料的复合材料的固化树脂体系。 该方法还包括使用接枝的甘油三酯来制造具有减少的有害空气污染物的增韧树脂和复合体系,而不显着降低玻璃化转变温度并显着提高粘度。

    ACID CATALYZED OLIGOMERIZATION OF ALKYL ESTERS AND CARBOXYLIC ACIDS
    16.
    发明申请
    ACID CATALYZED OLIGOMERIZATION OF ALKYL ESTERS AND CARBOXYLIC ACIDS 审中-公开
    酸性酯和羧酸的酸催化低聚

    公开(公告)号:US20140284520A1

    公开(公告)日:2014-09-25

    申请号:US14219728

    申请日:2014-03-19

    IPC分类号: C11C3/08

    摘要: The oligomerization of certain carboxylic acids and alkyl esters derived from natural oils is disclosed. This includes the oligomerization of C10-17 unsaturated carboxylic acids such as 9-decenoic acid, where the oligomerization yields a mixture of mono-, di- and tri-carboxylic acids. This also includes the oligomerization of certain alkyl esters, including the oligomerization of C10-17 unsaturated alkyl esters such as methyl 9-decenoate (9-DAME), where the oligomerization yields a mixture of mono-, di- and tri-carboxylic acid esters. Various end use applications for the oligomerized carboxylic acids and oligomerized alkyl esters are also disclosed.

    摘要翻译: 公开了某些衍生自天然油的羧酸和烷基酯的低聚。 这包括C10-17不饱和羧酸如9-癸烯酸的低聚,其中低聚产生单 - ,二 - 和三 - 羧酸的混合物。 这还包括某些烷基酯的低聚,包括C 10-17不饱和烷基酯如9-癸烯酸甲酯(9-DAME)的低聚,其中低聚产生单 - ,二 - 和三 - 羧酸酯的混合物 。 还公开了低聚羧酸和低聚烷基酯的各种最终应用。

    Lipid preparation for enhancing mineral absorption
    20.
    发明授权
    Lipid preparation for enhancing mineral absorption 有权
    用于增强矿物质吸收的脂质制剂

    公开(公告)号:US08618050B2

    公开(公告)日:2013-12-31

    申请号:US10576239

    申请日:2004-10-21

    IPC分类号: A61K38/00

    摘要: Disclosed is a dietary ingredient comprising at least one edible lipid which does not inhibit mineral absorption, enhances mineral absorption and intake, particularly a chemically or enzymatically synthesized synthetic oil, particularly glyceride-based lipid with high levels of mono- or polyunsaturated fatty acids at positions sn-1 and sn-3 of the glycerol backbone, vegetable- and plant-derived oil, such as flax and canola oils, short and medium chains lipid, preferably MCT and an oil mimicking the triglyceride composition of human mother's milk fat and its various uses.The dietary ingredient is particularly intended for use in enhancing calcium absorption and in the prevention and/or treatment of disorders associated with depletion of bone calcium and bone density, prevention and treatment of osteoporosis, for the enhancement of bone formation and bone mass maximization and for the enhancement of bone formation in infants and young children.

    摘要翻译: 公开了包含至少一种不抑制矿物质吸收的可食用脂质,增强矿物质吸收和摄入的膳食成分,特别是化学或酶合成的合成油,特别是甘油酯类脂质,其具有高水平的单不饱和脂肪酸或多不饱和脂肪酸 甘油骨架的sn-1和sn-3,植物和植物来源的油,例如亚麻和低芥酸菜子油,短链和中链脂质,优选MCT和模仿人母乳脂肪的甘油三酯组合物的油及其各种 用途。 膳食成分特别用于增强钙的吸收,以及预防和/或治疗与骨钙素和骨密度消耗相关的疾病,预防和治疗骨质疏松症,用于增强骨形成和骨量最大化以及 增强婴幼儿骨骼形成。